Cargando…

Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study

BACKGROUND: The aim of this work is to evaluate the performance of radiomics predictions for a range of molecular, genomic and clinical targets in patients with clear cell renal cell carcinoma (ccRCC) and demonstrate the impact of novel feature selection strategies and sub-segmentations on model int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orton, Matthew R., Hann, Evan, Doran, Simon J., Shepherd, Scott T. C., Ap Dafydd, Derfel, Spencer, Charlotte E., López, José I., Albarrán-Artahona, Víctor, Comito, Francesca, Warren, Hannah, Shur, Joshua, Messiou, Christina, Larkin, James, Turajlic, Samra, Koh, Dow-Mu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424427/ https://www.ncbi.nlm.nih.gov/pubmed/37580840 http://dx.doi.org/10.1186/s40644-023-00594-3

Ejemplares similares

Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
por: Fu, Xiao, et al.
Publicado: (2021)

Radiomics in Oncology: A Practical Guide
por: Shur, Joshua D., et al.
Publicado: (2021)

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
por: Mitchell, Thomas J., et al.
Publicado: (2018)

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
por: Turajlic, Samra, et al.
Publicado: (2018)

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
por: Turajlic, Samra, et al.
Publicado: (2018)

Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx
por: Karasaki, Takahiro, et al.
Publicado: (2023)

Body composition and lung cancer-associated cachexia in TRACERx
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

The evolution of lung cancer and impact of subclonal selection in TRACERx
por: Frankell, Alexander M., et al.
Publicado: (2023)

Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
por: Knill, Annemarie K., et al.
Publicado: (2022)

TracerX: Dynamic Symbolic Execution with Interpolation (Competition Contribution)
por: Jaffar, Joxan, et al.
Publicado: (2020)

The evolution of non-small cell lung cancer metastases in TRACERx
por: Al Bakir, Maise, et al.
Publicado: (2023)

Development of training-related health care software by a team of clinical educators: their experience, from conception to piloting
por: ap Dafydd, Derfel, et al.
Publicado: (2016)

Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
por: Jamal-Hanjani, Mariam, et al.
Publicado: (2014)

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
por: Abbosh, Christopher, et al.
Publicado: (2023)

“Real-world” radiomics from multi-vendor MRI: an original retrospective study on the prediction of nodal status and disease survival in breast cancer, as an exemplar to promote discussion of the wider issues
por: Doran, Simon J., et al.
Publicado: (2021)

New survival standards for advanced melanoma
por: Spain, Lavinia, et al.
Publicado: (2020)

Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram
por: Cheng, Delu, et al.
Publicado: (2023)

Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
por: Switzer, Benjamin, et al.
Publicado: (2021)

CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma
por: Chen, Menglin, et al.
Publicado: (2021)

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma
por: Yan, Lei, et al.
Publicado: (2021)

Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Gao, Ruizhi, et al.
Publicado: (2021)

Effectiveness of Radiomic ZOT Features in the Automated Discrimination of Oncocytoma from Clear Cell Renal Cancer
por: Carlini, Gianluca, et al.
Publicado: (2023)

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
por: Flynn, Michael, et al.
Publicado: (2018)

Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas
por: Wang, Ping, et al.
Publicado: (2021)

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
por: Au, Lewis, et al.
Publicado: (2021)

A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma
por: Meng, Xiaoli, et al.
Publicado: (2020)

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
por: Feng, Zhan, et al.
Publicado: (2020)

CT-Based Radiomics Signature for Preoperative Prediction of Coagulative Necrosis in Clear Cell Renal Cell Carcinoma
por: Xu, Kai, et al.
Publicado: (2020)

Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways
por: Lin, Peng, et al.
Publicado: (2021)

Computed tomography‐based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma
por: He, Hongchao, et al.
Publicado: (2022)

Multi-phase-combined CECT radiomics models for Fuhrman grade prediction of clear cell renal cell carcinoma
por: Zhou, Zhiyong, et al.
Publicado: (2023)

How we treat neurological toxicity from immune checkpoint inhibitors
por: Spain, Lavinia, et al.
Publicado: (2019)

A convention-radiomics CT nomogram for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma
por: Ma, Yanqing, et al.
Publicado: (2021)

Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Through CT-Based Tumoral and Peritumoral Radiomics
por: Ma, Yanqing, et al.
Publicado: (2022)

Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols
por: Budai, Bettina Katalin, et al.
Publicado: (2022)

The role of CT chest in screening for asymptomatic COVID-19 infection in self-isolating patients prior to elective oncological surgery: findings from a UK Cancer Hub
por: ap Dafydd, Derfel, et al.
Publicado: (2021)

Novel genetically engineered mouse models for clear cell renal cell carcinoma
por: van der Mijn, Johannes C., et al.
Publicado: (2023)

The Use of Radiomic Tools in Renal Mass Characterization
por: Gutiérrez Hidalgo, Beatriz, et al.
Publicado: (2023)

Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma
por: Li, Yajuan, et al.
Publicado: (2019)

Preoperative CT Radiomics Predicting the SSIGN Risk Groups in Patients With Clear Cell Renal Cell Carcinoma: Development and Multicenter Validation
por: Jiang, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ma2ljchrbr5htu163kgpfnmusl